ArticleEuropean journal of clinical pharmacology2021

Impact of histamine type-2 receptor antagonists on the anticancer efficacy of gefitinib in patients with non-small cell lung cancer.

Yoshitaka Saito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.